FACTS: Researchers in Australia, Canada, Germany, and Brazil are codifying a cure for Friedreich’s Ataxia and the University of Minnesota is at the crux of it all. Friedreich’s Ataxia Research Alliance is collaborating with the school in a study called TRACK-FA.
Alaxia is a rare neuromuscular disease that alters the central and peripheral nervous system.
Principle investigators of TRACK-FA study put their patients through a three part examination. A neurological and functional test, then blood is drawn, and then MRI scans of the brain and spinal chord are taken.
Study to begin in Summer 2022. Follow link below to become a patient in clinical trails.
QUOTES: Principle Investigator, Christophe Lenglet, PhD. “Clinical trial-ready biomarkers are going to be very important to reduce the number of people needed in a clinical trial, or shorten the time, and eventually develop treatments, and eventually cures for FA,”
BECOME A PATIENT: Click here
SOURCE: Friedreich’s Ataxia Alliance Research, TRACK-FA, click here.
